Applying drug-use evaluation principles to investigational or unlabeled drug use
Farber, M.S.; Garabedian-Ruffalo, S.M.
American Journal of Hospital Pharmacy 47(3): 598-599
1990
ISSN/ISBN: 0002-9289 PMID: 2138411 Document Number: 351001
Document emailed within 1 workday
Related Documents
Romansky, M.A. 1983: View from the Nation's Capital. Investigational new drug (IND) and new drug application (NDA) Journal of Clinical Psychopharmacology 3(3): 193-194Anandan, J.V.; Isopi, M.J.; Warren, A.J. 1993: Fee structure for investigational drug studies American Journal of Hospital Pharmacy 50(11): 2339-2343
Lagier, G.; Vincens, M.; Castot, A. 1983: Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid Therapie 38(3): 303-318
Rogers, S.D.; Lampasona, V.; Buchanan, E.C. 1994: The financial impact of investigational drug services Topics in Hospital Pharmacy Management 14(1): 60-66
Iteen, S.A.; Ceppaglia, J. 1992: Investigational drug information through a hospitalwide computer system American Journal of Hospital Pharmacy 49(11): 2746-2748
Zola, E.M.; Overbach, A.M.; Gunkel, J.H.; Mitchell, B.R.; Nagle, B.T.; DeMarco, N.G.; Henwood, G.A.; Gold, A.J. 1993: Treatment Investigational new Drug experience with Survanta (beractant) Pediatrics 91(3): 546-551
Tankanow, R.M.; Savitsky, M.E.; Volger, B.W.; Ryan, M.L.; Colvin, C.L. 1989: Quality assurance program for a hospital investigational-drug service American Journal of Hospital Pharmacy 46(5): 962-969
Grilley, B.J.; Trissel, L.A.; Bluml, B.M. 1991: Design and implementation of an electronic investigational drug accountability system American Journal of Hospital Pharmacy 48(12): 2616-2618
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Pedersen, P.A. 1975: Drug legislation and drug evaluation. Important aspects discussed in West Germany Ugeskrift for Laeger 137(6): 333-335
Yu, D.-h.; Huang, Y.; Jia, X.-b.; Zhu, J.; Liu, D.; Xiao, W. 2012: Drug releasing characteristics evaluation to multi-drug delivery system of tongmai pellets Zhongguo Zhong Yao Za Zhi 37(19): 2889-2893
Arditti, J.; Bourdon, J.H.; Jean, P.; Landi, H.; Nasset, D.; Jouglard, J.; Thirion, X. 1992: Buprenorphine abuse in a series of 50 drug addicts hospitalized at a Drug Dependence Evaluation hospital in Marseille Therapie 47(6): 561-562
Jackson, J.E.; Tally, J.D.; Ellis, W.Y.; Mebrahtu, Y.B.; Lawyer, P.G.; Were, J.B.; Reed, S.G.; Panisko, D.M.; Limmer, B.L. 1990: Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy American Journal of Tropical Medicine and Hygiene 43(5): 464-480
Ciorciaro, C.; Hartmann, K.; Kuhn, M. 1998: Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center) Schweizerische Medizinische Wochenschrift 128(7): 254-258
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Lu, J.-m.; Wang, J.; Huang, X.-c.; Hu, Z.-y.; Cui, Z.-l. 2011: Evaluation of microscopic observation drug susceptibility for drug susceptibility testing of mycobacterium tuberculosis in smear-positive sputum Zhonghua Yu Fang Yi Xue Za Zhi 45(1): 21-25
Savonitto, S.; Ambrosini, V.; Marzocchi, A.; Tolaro, S.; Petronio, A.S.; Galassi, A.R.; Bongo, A.S.; Gaglione, A.; Bolognese, L. 2005: Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(2): 106-118
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Suzanne de Treville; Ian Smith; Adrian Rölli; Virginia Arnold 2006: Applying operations management logic and tools to save lives: A case study of the world health organization's global drug facility Journal of Operations Management 24(4): 397-406